Detalles de la búsqueda
1.
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis.
Clin Gastroenterol Hepatol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729399
2.
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.
Diabetes Metab Res Rev
; 40(3): e3787, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38461408
3.
Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
Am J Physiol Gastrointest Liver Physiol
; 318(3): G410-G418, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31905026
4.
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis.
Hepatology
; 69(3): 1075-1086, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30014517
5.
Collagen biology and non-invasive biomarkers of liver fibrosis.
Liver Int
; 40(4): 736-750, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997561
6.
Is the Total Amount as Important as Localization and Type of Collagen in Liver Fibrosis Attributable to Steatohepatitis?
Hepatology
; 71(1): 346-351, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553813
7.
Safety, Tolerability, and Pharmacodynamics of AZD3366 (Optimized Human CD39L3 Apyrase) Alone and in Combination With Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo-Controlled Study.
J Am Heart Assoc
; 13(11): e033985, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804212
8.
Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Biomed Pharmacother
; 111: 926-933, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30841472
Resultados
1 -
8
de 8
1
Próxima >
>>